| Literature DB >> 27791265 |
Yanyan Wang1, Shaohua Fan2, Jun Lu2, Zifeng Zhang2, Dongmei Wu2, Zhiyong Wu3, Yuanlin Zheng2.
Abstract
Glutamate-ammonia ligase (GLUL) belongs to the glutamine synthetase family. It catalyzes the synthesis of glutamine from glutamate and ammonia in an ATP-dependent reaction. Here, we found higher expression of GLUL in the breast cancer patients was associated with larger tumor size and higher level of HER2 expression. In addition, GLUL was heterogeneously expressed in various breast cancer cells. The mRNA and protein expression levels of GLUL in SK-BR-3 cells were obviously higher than that in the other types of breast cancer cells. Results showed GLUL knockdown in SK-BR-3 cells could significantly decrease the proliferation ability. Furthermore, GLUL knockdown markedly inhibited the p38 MAPK and ERK1/ERK2 signaling pathways in SK-BR-3 cells. Thus, GLUL may represent a novel target for selectively inhibiting p38 MAPK and ERK1/ERK2 signaling pathways and the proliferation potential of breast cancer cells. J. Cell. Biochem. 118: 2018-2025, 2017.Entities:
Keywords: BREAST CANCER; GLUL; PROLIFERATION
Mesh:
Substances:
Year: 2017 PMID: 27791265 DOI: 10.1002/jcb.25775
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429